ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2010, Vol. 19 ›› Issue (4): 327-332.

• 论文 • 上一篇    下一篇

PPARγ激动剂抑制脂多糖诱导肾小管上皮细胞分泌因子及机制

  

  • 出版日期:2010-08-28 发布日期:2010-10-18
  • 基金资助:

    资助基金项目: 国家自然基金(30270613,30771000), 上海市重点学科基金(T0201), 上海市科委重大项目(08dz1900502)

Anti-inflammatory actions of PPAR? agonist in LPS-stimulated renal tubular epithelial cells

  • Online:2010-08-28 Published:2010-10-18

摘要:

目的:探讨过氧化物酶体增殖物激活受体γ激动剂15d-PGJ2对脂多糖诱导的趋化因子表达的影响及可能机制。方法:用15d-PGJ2( 5μM)预处理人近端肾小管上皮细胞2h后加入LPS (1μg/ml),与LPS组、15d-PGJ2组及未加任何刺激组进行比较。用Real-time PCR方法检测IL-8和MCP -1mRNA表达水平;用ELISA法检测细胞上清中IL-8和MCP-1蛋白水平;通过RNAi技术沉默肾小管上皮细胞PPARγ,观察15d-PGJ2的作用是否依赖于PPARγ;用间接免疫荧光法观察NF-κB在细胞内的定位;用Western blot法检测胞浆中IκB的磷酸化水平。结果:在HK-2细胞中,与对照组相比,LPS刺激4h使IL-8mRNA及蛋白分别升高(5.67±1.83)和(1.62±0.12)倍,使MCP-1mRNA及蛋白分别升高(5.24±1.33)和(2.25±0.40)倍,且胞浆中IκBα磷酸化水平明显增加(p<0.05)。与LPS组相比,15d- PGJ2 +LPS组,IL-8和MCP-1表达在mRNA水平分别下降74.23%和79.42%,在蛋白水平分别下降69.03%和49.44%,差异有统计学意义;在PPARγ沉默的HK-2细胞中,与LPS刺激组相比,15d-PGJ2使IL-8和MCP-1表达在mRNA水平分别下降59.21%和44.08%,在蛋白水平分别下降47.11%和39.40%(均p<0.05),并明显抑制LPS诱导NF-κB核易位,下调IκBα磷酸化水平。结论:15d-PGJ2可抑制LPS诱导的趋化因子表达,且不完全依赖于PPARγ,可能与抑制IκBα磷酸化有关。

关键词: PPAR&gamma, 激动剂, 15d-PGJ2, 趋化因子, 白介素-8, 单核细胞趋化蛋白-1

Abstract:

author: WANGWei-ming(E-mail:wweiming@medmail.com.cn)
ABSTRACT Objective:To investigate the anti-inflammatory actions of PPAR? agonist in LPS-stimulated renal tubular epithelial cells and further to clarify the mechanisms . Methodology: Human renal proximal tubular epithelial (HK-2) cells were divided into four groups: control, LPS (1μg/ml), 15d-PGJ2 (5μM), and 15d-PGJ2 (5μM)+LPS (1μg/ml). The expression of MCP-1 and IL-8 was measured by Real-time PCR and ELISA. To determine whether or not the inhibitory effects of 15d-PGJ2 were PPAR?-dependent RNAi experiments were performed. The location of NF-κB and the IκB phosphorylation was detected by immunofluorescence and western blot methods respectively. Results:The expressions of IL-8 and MCP-1 were increased by 5.67±1.83 and 5.24±1.33 times in mRNA level , 1.62±0.12 and 2.25±0.40 times in protein level respectively. In LPS-stimulated HK-2 cells (p<0.05), and the level of p-IκB in cytoplasm was significantly increased compared with control group. In 15d-PGJ2-pretreated cells, IL-8 and MCP-1 were decreased by 74.2%, 79.4% in mRNA level and 69.0%, 49.4% in protein level compared with LPS group (p<0.05). In pcDNA™6.2 -GW/ EmGFP–mi043-2-1 transfected cells, the levels of IL-8 and MCP-1 still was reduced by 59.2%, 44.1% in mRNA level and 47.1%, 39.4% in protein level in 15d-PGJ2+LPS group compared with LPS group. 15d-PGJ2 was significantly decreased LPS-induced IκB phosphorylation and NF-κB nuclear translocation in pcDNA™6.2 -GW/ EmGFP–mi043-2-1 transfected cells. Conclusions: 15d-PGJ2 inhibits LPS-induced chemokines expression, and are not entirely dependent on PPARγ, which may be related to inhibition of IκB phosphorylation.

Key words: PPAR , agonist, , 15d-PGJ2, chemokine, interleukin-8, monocyte chemoattractant protein-1